SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs has drawn attention, with traders citing BRIUMVIs sales growth and the Q3 results and subcutaneous Phase 3 data as key business catalysts. Buyout speculationparticularly involving Sanofiand hopes for short covering are widespread, but no deal is confirmed; some investors argue that execution matters more than takeover chatter.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is discussing access to a large number of U.S. cell sites have focused attention on Crown Castle as traders weigh potential new tower-leasing demand for Starlink Mobile. Bulls see a hybrid satellite-and-terrestrial network as a boost for tower owners, while skeptics note that no agreement is signed and question execution, regulatory approval, and whether speculation has already driven the move.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,075,967,326.643147 in circulation. The last known price of Algorand is 0.09515711 USD and is down -0.23 over the last 24 hours. It is currently trading on 586 active market(s) with $49,581,617.87 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGO is drawing attention around a contested recovery thesis: bullish traders cite technical support, rebounds and a possible altcoin rotation, while bears point to persistent underperformance and the risk of further declines. Some bulls also highlight Algorands quantum-resistant technology and tokenization or payment use cases, though these are longer-term narratives rather than a confirmed near-term catalyst.

Chainlink (LINK) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Chainlink has a current supply of 1,000,000,000 with 748,099,970.42488396 in circulation. The last known price of Chainlink is 11.67852871 USD and is up 2.18 over the last 24 hours. It is currently trading on 2313 active market(s) with $325,834,414.23 traded over the last 24 hours. More information can be found at https://chain.link/.

ChainLink

A volatile LINK rebound and repeated resistance tests are driving discussion, with bulls pointing to Chainlinks institutional and tokenization integrations, including its role in Coinbases Base tokenized-stock offering and CCIP 2.0. Skeptics warn that rallies have faded before and question whether network adoption will translate into value for the LINK token.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

BTDR is under pressure alongside Bitcoin miners and AI infrastructure stocks as traders cite Bitcoin weakness and a recent downgrade; some also blame short-selling, though that remains speculation. The community is split between calling the selloff an opportunity ahead of earnings and worrying the decline could continue, with many frustrated by BTDRs lagging performance versus peers.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas upcoming addition to the S&P 500 is a major topic, with traders weighing expected index-fund buying against a possible sell-the-news move as the shares weaken. Some posts also cite an alleged DHS-related breach, but those claims are unverified in the discussion.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grummans strong third-quarter results, higher full-year outlook and record backlog are driving discussion, with traders pointing to sustained defense demand. The reaction is mixed: some see the fundamentals as support for the shares, while others question the rally and expect a pullback.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is drawing attention after dazodalibep met its Phase 3 endpoint in Sjgrens disease, with traders viewing the result as a pipeline catalyst. The discussion also cites strong IMDELLTRA/Imfinzi small-cell lung cancer data, alongside questions about whether recent momentum is already priced in.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

A newly disclosed performance-based option award for CEO Gregory Demopulos is drawing attention, with traders debating whether its stock-price and service conditions align his incentives with shareholders. The broader discussion remains focused on YARTEMLEAs U.S. sales growth and the next quarterly results, with bullish expectations balanced by caution after the European regulatory rejection.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is drawing attention ahead of expected Q4 topline results from its Phase 3 HLP003 trial for major depressive disorder, a pivotal catalyst for the clinical-stage biotech. Traders are optimistic about the treatments potential as an add-on to existing antidepressants, but debate the binary trial risk, possible dilution and how results could compare with peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ABNB Stock Eyes Snapping 4-Week Losing Streak: KeyBanc Upgrades Airbnb On Hotel Growth, Valuation

Equity

KeyBanc upgrades the stock, citing durable core growth, rising hotel bookings, and an attractive valuation.


Forget Inflation: Funflation Is Here and These ETFs Are Riding on It 

ETFs like AWAY are riding on "funflation" as consumers keep spending on hobbies, travel, music and leisure despite higher prices.

Bet on Fourth of July Celebrations With These ETFs

July 4 travel is set to stay strong despite inflation and high gas prices. These ETFs could benefit from holiday spending trends.

UBER Stock In Spotlight After Company Backs Hydrogen Taxi Expansion In Europe

The partnership aims to boost zero-emission transport in taxis and ride-hailing services, supporting cleaner mobility in cities like Paris. 


Should You Avoid Travel ETFs Altogether Amid Iran Tensions?

Iran tensions are rattling global travel. Airline ETFs tumble, but diversified travel funds show resilience. Should investors avoid all travel ETFs or be selective?

SABR Stock Surges Nearly 32%, Hits 100-DMA For First Time In Nearly 9 Months – What’s The Connection With Constellation Software?

The company announced that its board adopted a limited-duration shareholder rights plan following Constellation Software's substantial increase in its stake in the company.

BKNG Stock Falls To Over 16-Month Lows – Brokerages Flag AI-Related Uncertainties

Multiple brokerages, including Barclays and Oppenheimer, slashed their price targets despite a better-than-expected fourth quarter print.

UBER Stock Slides After Earnings: EPS Miss Overshadows Strong Revenue Growth

Uber’s fourth-quarter adjusted earnings per share (EPS) of $0.71 came in below the analysts' consensus estimate of $0.78.

Royal Caribbean CEO Flags Historic Booking Momentum Heading Into 2026

In the fourth-quarter earnings call, Liberty stated that recent demand trends show continued strength across pricing and occupancy.

Why Did MakeMyTrip Stock Fall Today?

MakeMyTrip Ltd. received target price cuts from Morgan Stanley and Citi following its third-quarter results that were below market expectations. 

Amplify ETF Trust - Amplify Travel Tech ETF

Neutral Sentiment

<ul class="summary-bullets"><li>KeyBanc upgraded Airbnb to Overweight with a $191 price target, implying a 19% upside.&nbsp;</li><li>The firm believes hotels could be a second long-term growth driver for Airbnb.</li><li>KeyBanc said Airbnb is trading at a discount compared to its lodging peers.</li></ul><p>&nbsp;Airbnb Inc. (<a class="mention" data-mention="$ABNB" data-symbol-id="ABNB" href="https://stocktwits.com/symbol/ABNB" target="_blank">ABNB</a>) stock is looking to snap a four-week losing streak after KeyBanc upgraded the travel rental platform to ‘Overweight’. The firm sees the company’s core business maintaining solid growth, while expanding hotel bookings could&nbsp;add momentum, with shares trading below historical valuation levels.&nbsp;</p><p><a href="https://stocktwits.com/symbol/ABNB">Airbnb stock</a> edged nearly 1% higher overnight Thursday. The stock is up nearly 2% so far this week. September was Airbnb’s worst month since March 2025.&nbsp;</p><h2 class="st-heading-2">Airbnb Hotels Add Another Growth Avenue</h2><p>KeyBanc analyst Sergio Segura upgraded Airbnb to ‘Overweight’ from ‘Sector Weight’ and assigned a $191 price target, implying a 19% upside to the stock’s last closing price.&nbsp;</p><p>Segura said Airbnb’s main business is showing signs of becoming more durable, with new products helping support its expansion. The analyst believes the company’s growth is increasingly being driven by its product strategy rather than temporary factors.</p><p>Airbnb’s hotel business is also gaining importance. KeyBanc views hotel bookings as a potential second engine that could add to the company’s longer-term growth as the platform expands beyond its traditional short-term rental base.</p><h2 class="st-heading-2">Airbnb’s Valuation Looks More Attractive</h2><p>The analyst noted that Airbnb’s shares are trading below their median valuation level from the past three years. The stock also trades at a discount to established lodging companies, despite what KeyBanc sees as stronger growth and improving operating momentum.</p><p>Last month, Citizens analyst Matthew Condon also raised Airbnb’s price target to $200 from $190 while keeping an ‘Outperform’ rating. He sees hotel expansion and AI-powered pricing tools as key growth drivers through the second half of 2026 and into 2027.&nbsp;</p><p>In its fiscal second-quarter (Q2) earnings, the company said about 35% of first-time guests who book a hotel through Airbnb later return to book a home. Hotels still make up a single-digit percentage of total bookings, but they are growing quickly. Airbnb’s Hotel bookings are increasing at about three times the rate of its home business.&nbsp;</p><p>On Wednesday, Airbnb said it is expanding its travel platform with new social features and AI-powered planning tools. Travelers in the U.S. can use natural language or voice to search for homes, experiences, and services. AI-powered filters can identify relevant amenities based on simple keywords, while AI-generated summaries will highlight key listing features.</p><h2 class="st-heading-2"><a class="mention" data-mention="$ABNB" data-symbol-id="ABNB" href="https://stocktwits.com/symbol/ABNB" target="_blank">ABNB</a> Stock: Retail Stance&nbsp;</h2><p>On Stocktwits, retail sentiment around the stock improved to ‘bullish’ from ‘neutral’ the previous day.&nbsp;</p><p><a class="mention" data-mention="$ABNB" data-symbol-id="ABNB" href="https://stocktwits.com/symbol/ABNB" target="_blank">ABNB</a> stock has gained over 18% year-to-date.&nbsp;</p><p>Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/on-syna-climb-after-hours-as-the-7-b-stock-deal-becomes-a-5-7-b-cash-bid/cZD0SPiRB0i">ON, SYNA Climb After-Hours As The $7B Stock Deal Becomes A $5.7B Cash Bid</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

 In this photo illustration, an Airbnb logo is displayed on a smartphone and in the background.

Airbnb Inc. (ABNB) stock is looking to snap a four-week losing streak after KeyBanc upgraded the travel rental platform to ‘Overweight’. The firm sees the company’s core business maintaining solid growth, while expanding hotel bookings could add momentum,

Airbnb Inc

Amplify Travel Tech ETF

Invesco Dynamic Leisure and Entertainment ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

AWAY Amplify Travel Tech ETF

Fundamentals

Latest AWAY News